The Department of Health of Abu Dhabi is advancing precision medicine for Alzheimer’s disease by incorporating APOE E4 genotyping into its pharmacogenomics (PGx) reports. This initiative, in collaboration with M42’s Biogenix Lab, aims to enhance treatment customization based on individual genetic profiles. The updated PGx reports will enable healthcare providers to tailor treatments according to...
The Department of Health – Abu Dhabi has introduced a significant Declaration on Longevity and Precision Medicine during the Abu Dhabi Global Health Week 2025. This initiative marks a pivotal step in enhancing healthcare delivery and research on a global scale. Developed in partnership with prominent international health organizations, academic institutions, and industry leaders, the...
The Department of Health Abu Dhabi (DoH), the regulatory body for the healthcare sector in the Emirate, has partnered with Oliver Wyman, a global management consulting firm, to unveil a significant report titled “Genomics For Longevity.” This report was released during the Abu Dhabi Global Health Week (ADGHW) and explores the transformative potential of genomics...
The Department of Health – Abu Dhabi (DoH) has signed a significant Memorandum of Understanding (MoU) with various global and local leaders in the healthcare sector. This agreement aims to create a collaborative framework that will advance the future of healthcare through precision medicine and innovative therapies. Key partners in this initiative include PureHealth, Khalifa...
The United Arab Emirates has signed a significant agreement with the pharmaceutical giant GSK to collaborate on genomic science and precision medicine. This partnership aims to enhance health initiatives in the region, reflecting Abu Dhabi’s commitment to advancing healthcare through innovative scientific research. GSK’s Chief Executive Officer highlighted the project as “bold,” emphasizing its potential...
The Department of Health – Abu Dhabi (DoH), the Abu Dhabi Investment Office (ADIO), and GSK, a global leader in biopharmaceuticals, have joined forces to establish a Multi-Omics Research Institute in Abu Dhabi. This partnership was formalized with a Memorandum of Understanding (MoU) signed during the Abu Dhabi Global Health Week (ADGHW). The initiative aims...
Artificial intelligence is making waves in healthcare, and the UAE is at the forefront of this transformation. M42, a global leader in health powered by AI, is pioneering innovative solutions to improve patient care, enhance decision-making, and reduce the burden on clinicians. Speaking to Emirates News Agency (WAM) ahead of Arab Health 2025, Dr. Maaz...